Combining its long experience in natural product extraction and the ALPAFLOR® philosophy, DSM Nutritional Products Ltd Branch PENTAPHARM developed ALPAFLOR® ABI COMPLEX AO, a new natural Ecocert certified treatment for irritated and sensitive skins. This new plant extract, from the ALP®-ORGANIC product line, is produced from the Alpine plants Artemisia umbelliformis Lam., Buddleja davidii and Peucedanum ostruthium L. These plants, well-known in traditional medicine, have cosmetic applications supported by scientific tests.

ALPAFLOR® ABI COMPLEX AO can have the following cosmetic applications:

• After-shave balms or lotions to sooth and repair irritated skin.
• Sun or after sun care creams to protect from environmental harmful influences and to repair the skin.
• Day and night care products to protect and restore mature skin.
• Cleansing and purifying preparations to calm and protect sensitive skin.
• Natural and/or organic cosmetic formulations.

With ALPAFLOR®, DSM Nutritional Products Ltd Branch PENTAPHARM has developed a unique approach to cultivate Swiss alpine plants for high quality extracts. The alpine plants' daily exposure to strong temperature fluctuations and high UV radiation force these species to develop efficient protective factors. These characteristics are now used for application in skin and hair care ingredients.

The plants used for the ALPAFLOR® product line are cultivated in the Swiss Alps, controlled by Bio.inspecta and certified by Bio Swiss. Well-known ingredients from ALPAFLOR® are EDELWEISS, NECTAPURE, ALP®-SEBUM and the ALP®-ORGANIC product line.

About DSM Nutritional Products
DSM Nutritional Products is the world's leading supplier of vitamins, carotenoids and other fine chemicals to the feed, food, pharmaceutical and personal care industries. The business has sales of over EUR 2 billion and a long tradition as a pioneer in the discovery of new products, new formulations and attractive applications for all industry segments. For further company information please visit www.dsmnutritionalproducts.com.

About DSM Nutritional Products Ltd. Branch PENTAPHARM
DSM Nutritional Products Ltd Branch PENTAPHARM produces innovative active ingredients for the pharmaceutical, diagnostic and cosmetic industry. Its core competencies are the extraction of active ingredients from natural sources, purification and characterization of snake venom enzymes, synthesis of small peptides and peptide-like substances and biotechnological manufacturing of active ingredients. On August 29th, 2007 the ownership of PENTAPHARM was transferred to DSM Nutritional Products AG (headquarter Kaiseraugst / Switzerland). www.pentapharm.com

DSM – the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM’s products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. DSM has annual sales of almost EUR 8.8 billion and employs some 23,000 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com.

ALPAFLOR® is a registered trademark of DSM

For more information:
DSM Nutritional Products Ltd Branch PENTAPHARM
Christine Stamm
Tel: +41 61 319 96 45
E-mail: christine.stamm@pentapharm.com

DSM Nutritional Products
Emma Peyrachon - Europe
Tel. +41 (0) 61 815 89 34
E-mail: emma.peyrachon@dsm.com

Forward-looking statements
This press release contains forward-looking statements. These statements are based on current expectations, estimates and projections of DSM and information currently available to the company. The statements involve certain risks and uncertainties that are difficult to predict and therefore DSM does not guarantee that its expectations will be realized. Furthermore, DSM has no obligation to update the statements contained in this press release. The English language version of the press release is leading.